nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Trimethadione—epilepsy syndrome	0.0408	0.077	CbGbCtD
Bexarotene—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0383	0.0724	CbGbCtD
Bexarotene—CYP2C9—Carbamazepine—epilepsy syndrome	0.0275	0.052	CbGbCtD
Bexarotene—CYP2C9—Primidone—epilepsy syndrome	0.0257	0.0485	CbGbCtD
Bexarotene—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0255	0.0481	CbGbCtD
Bexarotene—CYP2C9—Phenytoin—epilepsy syndrome	0.0247	0.0466	CbGbCtD
Bexarotene—CYP3A4—Felbamate—epilepsy syndrome	0.0237	0.0448	CbGbCtD
Bexarotene—CYP3A4—Trimethadione—epilepsy syndrome	0.0237	0.0448	CbGbCtD
Bexarotene—CYP2C9—Propofol—epilepsy syndrome	0.023	0.0435	CbGbCtD
Bexarotene—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0223	0.0421	CbGbCtD
Bexarotene—CYP2C9—Phenobarbital—epilepsy syndrome	0.022	0.0416	CbGbCtD
Bexarotene—CYP2C9—Diazepam—epilepsy syndrome	0.0209	0.0394	CbGbCtD
Bexarotene—CYP3A4—Clonazepam—epilepsy syndrome	0.0201	0.0381	CbGbCtD
Bexarotene—CYP3A4—Clobazam—epilepsy syndrome	0.0193	0.0365	CbGbCtD
Bexarotene—CYP2C9—Valproic Acid—epilepsy syndrome	0.0164	0.0311	CbGbCtD
Bexarotene—CYP3A4—Rufinamide—epilepsy syndrome	0.0164	0.031	CbGbCtD
Bexarotene—CYP3A4—Carbamazepine—epilepsy syndrome	0.016	0.0302	CbGbCtD
Bexarotene—CYP3A4—Primidone—epilepsy syndrome	0.0149	0.0282	CbGbCtD
Bexarotene—CYP3A4—Phenytoin—epilepsy syndrome	0.0144	0.0271	CbGbCtD
Bexarotene—CYP3A4—Propofol—epilepsy syndrome	0.0134	0.0253	CbGbCtD
Bexarotene—CYP3A4—Acetazolamide—epilepsy syndrome	0.0128	0.0242	CbGbCtD
Bexarotene—CYP3A4—Phenobarbital—epilepsy syndrome	0.0128	0.0242	CbGbCtD
Bexarotene—CYP3A4—Midazolam—epilepsy syndrome	0.0126	0.0238	CbGbCtD
Bexarotene—CYP3A4—Diazepam—epilepsy syndrome	0.0121	0.0229	CbGbCtD
Bexarotene—CYP3A4—Zonisamide—epilepsy syndrome	0.0118	0.0224	CbGbCtD
Bexarotene—CYP3A4—Valproic Acid—epilepsy syndrome	0.00956	0.0181	CbGbCtD
Bexarotene—CYP3A4—Topiramate—epilepsy syndrome	0.00863	0.0163	CbGbCtD
Bexarotene—RXRA—ganglion—epilepsy syndrome	0.00718	0.183	CbGeAlD
Bexarotene—RXRA—forebrain—epilepsy syndrome	0.00301	0.0769	CbGeAlD
Bexarotene—RXRA—telencephalon—epilepsy syndrome	0.00277	0.0707	CbGeAlD
Bexarotene—RXRB—telencephalon—epilepsy syndrome	0.00229	0.0583	CbGeAlD
Bexarotene—RXRG—medulla oblongata—epilepsy syndrome	0.00191	0.0487	CbGeAlD
Bexarotene—RXRG—midbrain—epilepsy syndrome	0.00175	0.0446	CbGeAlD
Bexarotene—RXRA—head—epilepsy syndrome	0.00173	0.044	CbGeAlD
Bexarotene—RXRG—spinal cord—epilepsy syndrome	0.0017	0.0435	CbGeAlD
Bexarotene—RXRA—nervous system—epilepsy syndrome	0.00164	0.0417	CbGeAlD
Bexarotene—RXRA—central nervous system—epilepsy syndrome	0.00157	0.0402	CbGeAlD
Bexarotene—RXRG—head—epilepsy syndrome	0.00151	0.0386	CbGeAlD
Bexarotene—RXRG—nervous system—epilepsy syndrome	0.00144	0.0366	CbGeAlD
Bexarotene—RXRB—head—epilepsy syndrome	0.00142	0.0363	CbGeAlD
Bexarotene—RXRG—central nervous system—epilepsy syndrome	0.00138	0.0353	CbGeAlD
Bexarotene—RXRB—nervous system—epilepsy syndrome	0.00135	0.0344	CbGeAlD
Bexarotene—RXRB—central nervous system—epilepsy syndrome	0.0013	0.0332	CbGeAlD
Bexarotene—RXRB—cerebellum—epilepsy syndrome	0.00127	0.0324	CbGeAlD
Bexarotene—RXRA—brain—epilepsy syndrome	0.00125	0.0319	CbGeAlD
Bexarotene—RXRG—brain—epilepsy syndrome	0.0011	0.028	CbGeAlD
Bexarotene—RXRB—brain—epilepsy syndrome	0.00103	0.0263	CbGeAlD
Bexarotene—CYP3A4—nervous system—epilepsy syndrome	0.000302	0.00771	CbGeAlD
Bexarotene—CYP3A4—central nervous system—epilepsy syndrome	0.000291	0.00743	CbGeAlD
Bexarotene—RXRA—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.36e-05	0.000621	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—JUNB—epilepsy syndrome	5.31e-05	0.000614	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NEU1—epilepsy syndrome	5.28e-05	0.000611	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—UPB1—epilepsy syndrome	5.28e-05	0.000611	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ATIC—epilepsy syndrome	5.28e-05	0.000611	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	5.25e-05	0.000608	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—DLG4—epilepsy syndrome	5.24e-05	0.000607	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	5.16e-05	0.000598	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—GRIN2B—epilepsy syndrome	5.12e-05	0.000593	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HSD17B4—epilepsy syndrome	5.08e-05	0.000588	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—JUNB—epilepsy syndrome	4.99e-05	0.000578	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	4.98e-05	0.000577	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	4.92e-05	0.000569	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GBE1—epilepsy syndrome	4.91e-05	0.000568	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPP1R3C—epilepsy syndrome	4.91e-05	0.000568	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.85e-05	0.000562	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.84e-05	0.00056	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.8e-05	0.000555	CbGpPWpGaD
Bexarotene—Urethral disorder—Topiramate—epilepsy syndrome	4.79e-05	0.000139	CcSEcCtD
Bexarotene—Pruritus—Oxcarbazepine—epilepsy syndrome	4.78e-05	0.000139	CcSEcCtD
Bexarotene—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.78e-05	0.000138	CcSEcCtD
Bexarotene—Headache—Vigabatrin—epilepsy syndrome	4.76e-05	0.000138	CcSEcCtD
Bexarotene—Hypertension—Pregabalin—epilepsy syndrome	4.76e-05	0.000138	CcSEcCtD
Bexarotene—Vomiting—Diazepam—epilepsy syndrome	4.76e-05	0.000138	CcSEcCtD
Bexarotene—Anorexia—Valproic Acid—epilepsy syndrome	4.74e-05	0.000138	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	4.73e-05	0.000548	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT3—epilepsy syndrome	4.73e-05	0.000547	CbGpPWpGaD
Bexarotene—Rash—Diazepam—epilepsy syndrome	4.72e-05	0.000137	CcSEcCtD
Bexarotene—Dermatitis—Diazepam—epilepsy syndrome	4.72e-05	0.000137	CcSEcCtD
Bexarotene—Chest pain—Pregabalin—epilepsy syndrome	4.69e-05	0.000136	CcSEcCtD
Bexarotene—Arthralgia—Pregabalin—epilepsy syndrome	4.69e-05	0.000136	CcSEcCtD
Bexarotene—Myalgia—Pregabalin—epilepsy syndrome	4.69e-05	0.000136	CcSEcCtD
Bexarotene—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.69e-05	0.000136	CcSEcCtD
Bexarotene—Dizziness—Zonisamide—epilepsy syndrome	4.69e-05	0.000136	CcSEcCtD
Bexarotene—Headache—Diazepam—epilepsy syndrome	4.69e-05	0.000136	CcSEcCtD
Bexarotene—Anxiety—Pregabalin—epilepsy syndrome	4.68e-05	0.000136	CcSEcCtD
Bexarotene—Diarrhoea—Clonazepam—epilepsy syndrome	4.68e-05	0.000136	CcSEcCtD
Bexarotene—Anaemia—Gabapentin—epilepsy syndrome	4.67e-05	0.000135	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.66e-05	0.000135	CcSEcCtD
Bexarotene—Asthenia—Carbamazepine—epilepsy syndrome	4.65e-05	0.000135	CcSEcCtD
Bexarotene—Agitation—Gabapentin—epilepsy syndrome	4.65e-05	0.000135	CcSEcCtD
Bexarotene—Diarrhoea—Phenytoin—epilepsy syndrome	4.65e-05	0.000135	CcSEcCtD
Bexarotene—Discomfort—Pregabalin—epilepsy syndrome	4.64e-05	0.000134	CcSEcCtD
Bexarotene—Nausea—Fosphenytoin—epilepsy syndrome	4.63e-05	0.000134	CcSEcCtD
Bexarotene—RXRA—Gene Expression—SNRPE—epilepsy syndrome	4.63e-05	0.000536	CbGpPWpGaD
Bexarotene—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.62e-05	0.000134	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—ADAM10—epilepsy syndrome	4.62e-05	0.000535	CbGpPWpGaD
Bexarotene—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.62e-05	0.000134	CcSEcCtD
Bexarotene—RXRA—Metabolism—ASAH1—epilepsy syndrome	4.61e-05	0.000534	CbGpPWpGaD
Bexarotene—Vomiting—Felbamate—epilepsy syndrome	4.61e-05	0.000134	CcSEcCtD
Bexarotene—Dry mouth—Pregabalin—epilepsy syndrome	4.59e-05	0.000133	CcSEcCtD
Bexarotene—Pruritus—Carbamazepine—epilepsy syndrome	4.59e-05	0.000133	CcSEcCtD
Bexarotene—Rash—Felbamate—epilepsy syndrome	4.57e-05	0.000132	CcSEcCtD
Bexarotene—Eye disorder—Topiramate—epilepsy syndrome	4.57e-05	0.000132	CcSEcCtD
Bexarotene—Dermatitis—Felbamate—epilepsy syndrome	4.56e-05	0.000132	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.56e-05	0.000528	CbGpPWpGaD
Bexarotene—Malaise—Gabapentin—epilepsy syndrome	4.56e-05	0.000132	CcSEcCtD
Bexarotene—Tinnitus—Topiramate—epilepsy syndrome	4.56e-05	0.000132	CcSEcCtD
Bexarotene—Vertigo—Gabapentin—epilepsy syndrome	4.54e-05	0.000132	CcSEcCtD
Bexarotene—Headache—Felbamate—epilepsy syndrome	4.54e-05	0.000132	CcSEcCtD
Bexarotene—Confusional state—Pregabalin—epilepsy syndrome	4.54e-05	0.000132	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.54e-05	0.000525	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.54e-05	0.000131	CcSEcCtD
Bexarotene—Cardiac disorder—Topiramate—epilepsy syndrome	4.54e-05	0.000131	CcSEcCtD
Bexarotene—Syncope—Gabapentin—epilepsy syndrome	4.53e-05	0.000131	CcSEcCtD
Bexarotene—Leukopenia—Gabapentin—epilepsy syndrome	4.53e-05	0.000131	CcSEcCtD
Bexarotene—Dizziness—Clonazepam—epilepsy syndrome	4.52e-05	0.000131	CcSEcCtD
Bexarotene—Nausea—Vigabatrin—epilepsy syndrome	4.52e-05	0.000131	CcSEcCtD
Bexarotene—Vomiting—Zonisamide—epilepsy syndrome	4.51e-05	0.000131	CcSEcCtD
Bexarotene—Insomnia—Valproic Acid—epilepsy syndrome	4.5e-05	0.00013	CcSEcCtD
Bexarotene—Oedema—Pregabalin—epilepsy syndrome	4.5e-05	0.00013	CcSEcCtD
Bexarotene—Asthenia—Lamotrigine—epilepsy syndrome	4.49e-05	0.00013	CcSEcCtD
Bexarotene—Dizziness—Phenytoin—epilepsy syndrome	4.49e-05	0.00013	CcSEcCtD
Bexarotene—RXRA—Metabolism—STXBP1—epilepsy syndrome	4.49e-05	0.000519	CbGpPWpGaD
Bexarotene—Rash—Zonisamide—epilepsy syndrome	4.47e-05	0.00013	CcSEcCtD
Bexarotene—Infection—Pregabalin—epilepsy syndrome	4.47e-05	0.00013	CcSEcCtD
Bexarotene—Paraesthesia—Valproic Acid—epilepsy syndrome	4.47e-05	0.00013	CcSEcCtD
Bexarotene—Palpitations—Gabapentin—epilepsy syndrome	4.47e-05	0.00013	CcSEcCtD
Bexarotene—Dermatitis—Zonisamide—epilepsy syndrome	4.47e-05	0.00013	CcSEcCtD
Bexarotene—Dizziness—Oxcarbazepine—epilepsy syndrome	4.47e-05	0.000129	CcSEcCtD
Bexarotene—Nausea—Diazepam—epilepsy syndrome	4.45e-05	0.000129	CcSEcCtD
Bexarotene—Loss of consciousness—Gabapentin—epilepsy syndrome	4.44e-05	0.000129	CcSEcCtD
Bexarotene—Headache—Zonisamide—epilepsy syndrome	4.44e-05	0.000129	CcSEcCtD
Bexarotene—Dyspnoea—Valproic Acid—epilepsy syndrome	4.44e-05	0.000129	CcSEcCtD
Bexarotene—Diarrhoea—Carbamazepine—epilepsy syndrome	4.43e-05	0.000129	CcSEcCtD
Bexarotene—Angiopathy—Topiramate—epilepsy syndrome	4.43e-05	0.000129	CcSEcCtD
Bexarotene—Pruritus—Lamotrigine—epilepsy syndrome	4.43e-05	0.000128	CcSEcCtD
Bexarotene—Shock—Pregabalin—epilepsy syndrome	4.43e-05	0.000128	CcSEcCtD
Bexarotene—Somnolence—Valproic Acid—epilepsy syndrome	4.43e-05	0.000128	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.42e-05	0.000512	CbGpPWpGaD
Bexarotene—Nervous system disorder—Pregabalin—epilepsy syndrome	4.41e-05	0.000128	CcSEcCtD
Bexarotene—Cough—Gabapentin—epilepsy syndrome	4.41e-05	0.000128	CcSEcCtD
Bexarotene—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.41e-05	0.000128	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	4.39e-05	0.000509	CbGpPWpGaD
Bexarotene—Tachycardia—Pregabalin—epilepsy syndrome	4.39e-05	0.000127	CcSEcCtD
Bexarotene—Chills—Topiramate—epilepsy syndrome	4.38e-05	0.000127	CcSEcCtD
Bexarotene—Dyspepsia—Valproic Acid—epilepsy syndrome	4.38e-05	0.000127	CcSEcCtD
Bexarotene—RXRA—Metabolism—NT5E—epilepsy syndrome	4.37e-05	0.000506	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALAD—epilepsy syndrome	4.37e-05	0.000506	CbGpPWpGaD
Bexarotene—Skin disorder—Pregabalin—epilepsy syndrome	4.37e-05	0.000127	CcSEcCtD
Bexarotene—Hypertension—Gabapentin—epilepsy syndrome	4.37e-05	0.000127	CcSEcCtD
Bexarotene—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.35e-05	0.000126	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.35e-05	0.000504	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—epilepsy syndrome	4.35e-05	0.000503	CbGpPWpGaD
Bexarotene—Vomiting—Clonazepam—epilepsy syndrome	4.35e-05	0.000126	CcSEcCtD
Bexarotene—Decreased appetite—Valproic Acid—epilepsy syndrome	4.33e-05	0.000125	CcSEcCtD
Bexarotene—Alopecia—Topiramate—epilepsy syndrome	4.32e-05	0.000125	CcSEcCtD
Bexarotene—Vomiting—Phenytoin—epilepsy syndrome	4.32e-05	0.000125	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—CDC42—epilepsy syndrome	4.31e-05	0.000499	CbGpPWpGaD
Bexarotene—Rash—Clonazepam—epilepsy syndrome	4.31e-05	0.000125	CcSEcCtD
Bexarotene—Dermatitis—Clonazepam—epilepsy syndrome	4.31e-05	0.000125	CcSEcCtD
Bexarotene—Arthralgia—Gabapentin—epilepsy syndrome	4.3e-05	0.000125	CcSEcCtD
Bexarotene—Myalgia—Gabapentin—epilepsy syndrome	4.3e-05	0.000125	CcSEcCtD
Bexarotene—Chest pain—Gabapentin—epilepsy syndrome	4.3e-05	0.000125	CcSEcCtD
Bexarotene—Nausea—Felbamate—epilepsy syndrome	4.3e-05	0.000125	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.3e-05	0.000125	CcSEcCtD
Bexarotene—Vomiting—Oxcarbazepine—epilepsy syndrome	4.29e-05	0.000124	CcSEcCtD
Bexarotene—Fatigue—Valproic Acid—epilepsy syndrome	4.29e-05	0.000124	CcSEcCtD
Bexarotene—Anxiety—Gabapentin—epilepsy syndrome	4.29e-05	0.000124	CcSEcCtD
Bexarotene—Anorexia—Pregabalin—epilepsy syndrome	4.29e-05	0.000124	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—VDR—epilepsy syndrome	4.29e-05	0.000496	CbGpPWpGaD
Bexarotene—Dizziness—Carbamazepine—epilepsy syndrome	4.29e-05	0.000124	CcSEcCtD
Bexarotene—Diarrhoea—Lamotrigine—epilepsy syndrome	4.29e-05	0.000124	CcSEcCtD
Bexarotene—Headache—Clonazepam—epilepsy syndrome	4.28e-05	0.000124	CcSEcCtD
Bexarotene—Rash—Phenytoin—epilepsy syndrome	4.28e-05	0.000124	CcSEcCtD
Bexarotene—Dermatitis—Phenytoin—epilepsy syndrome	4.28e-05	0.000124	CcSEcCtD
Bexarotene—RXRG—Gene Expression—SIRT1—epilepsy syndrome	4.28e-05	0.000495	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.28e-05	0.000124	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	4.27e-05	0.000494	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.26e-05	0.000493	CbGpPWpGaD
Bexarotene—Rash—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000123	CcSEcCtD
Bexarotene—Constipation—Valproic Acid—epilepsy syndrome	4.26e-05	0.000123	CcSEcCtD
Bexarotene—Pain—Valproic Acid—epilepsy syndrome	4.26e-05	0.000123	CcSEcCtD
Bexarotene—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.25e-05	0.000123	CcSEcCtD
Bexarotene—Headache—Phenytoin—epilepsy syndrome	4.25e-05	0.000123	CcSEcCtD
Bexarotene—Erythema—Topiramate—epilepsy syndrome	4.25e-05	0.000123	CcSEcCtD
Bexarotene—Malnutrition—Topiramate—epilepsy syndrome	4.25e-05	0.000123	CcSEcCtD
Bexarotene—Discomfort—Gabapentin—epilepsy syndrome	4.25e-05	0.000123	CcSEcCtD
Bexarotene—Headache—Oxcarbazepine—epilepsy syndrome	4.23e-05	0.000123	CcSEcCtD
Bexarotene—RXRG—Gene Expression—VDR—epilepsy syndrome	4.21e-05	0.000488	CbGpPWpGaD
Bexarotene—Nausea—Zonisamide—epilepsy syndrome	4.21e-05	0.000122	CcSEcCtD
Bexarotene—Dry mouth—Gabapentin—epilepsy syndrome	4.21e-05	0.000122	CcSEcCtD
Bexarotene—Flatulence—Topiramate—epilepsy syndrome	4.19e-05	0.000121	CcSEcCtD
Bexarotene—Tension—Topiramate—epilepsy syndrome	4.17e-05	0.000121	CcSEcCtD
Bexarotene—RXRA—Metabolism—ALDH7A1—epilepsy syndrome	4.17e-05	0.000483	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CACNA1A—epilepsy syndrome	4.17e-05	0.000483	CbGpPWpGaD
Bexarotene—Dysgeusia—Topiramate—epilepsy syndrome	4.17e-05	0.000121	CcSEcCtD
Bexarotene—Confusional state—Gabapentin—epilepsy syndrome	4.16e-05	0.000121	CcSEcCtD
Bexarotene—Dizziness—Lamotrigine—epilepsy syndrome	4.14e-05	0.00012	CcSEcCtD
Bexarotene—Nervousness—Topiramate—epilepsy syndrome	4.13e-05	0.00012	CcSEcCtD
Bexarotene—Oedema—Gabapentin—epilepsy syndrome	4.13e-05	0.00012	CcSEcCtD
Bexarotene—Vomiting—Carbamazepine—epilepsy syndrome	4.12e-05	0.000119	CcSEcCtD
Bexarotene—Back pain—Topiramate—epilepsy syndrome	4.11e-05	0.000119	CcSEcCtD
Bexarotene—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.1e-05	0.000119	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.1e-05	0.000119	CcSEcCtD
Bexarotene—Infection—Gabapentin—epilepsy syndrome	4.1e-05	0.000119	CcSEcCtD
Bexarotene—Muscle spasms—Topiramate—epilepsy syndrome	4.09e-05	0.000119	CcSEcCtD
Bexarotene—Rash—Carbamazepine—epilepsy syndrome	4.09e-05	0.000118	CcSEcCtD
Bexarotene—Dermatitis—Carbamazepine—epilepsy syndrome	4.08e-05	0.000118	CcSEcCtD
Bexarotene—RXRA—Metabolism—ST3GAL3—epilepsy syndrome	4.08e-05	0.000473	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.07e-05	0.000118	CcSEcCtD
Bexarotene—Insomnia—Pregabalin—epilepsy syndrome	4.07e-05	0.000118	CcSEcCtD
Bexarotene—Nausea—Clonazepam—epilepsy syndrome	4.06e-05	0.000118	CcSEcCtD
Bexarotene—Headache—Carbamazepine—epilepsy syndrome	4.06e-05	0.000118	CcSEcCtD
Bexarotene—Shock—Gabapentin—epilepsy syndrome	4.06e-05	0.000118	CcSEcCtD
Bexarotene—Nervous system disorder—Gabapentin—epilepsy syndrome	4.05e-05	0.000117	CcSEcCtD
Bexarotene—Paraesthesia—Pregabalin—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Bexarotene—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Bexarotene—Nausea—Phenytoin—epilepsy syndrome	4.03e-05	0.000117	CcSEcCtD
Bexarotene—Tachycardia—Gabapentin—epilepsy syndrome	4.03e-05	0.000117	CcSEcCtD
Bexarotene—RXRB—Gene Expression—SIRT1—epilepsy syndrome	4.02e-05	0.000465	CbGpPWpGaD
Bexarotene—Dyspnoea—Pregabalin—epilepsy syndrome	4.01e-05	0.000116	CcSEcCtD
Bexarotene—Nausea—Oxcarbazepine—epilepsy syndrome	4.01e-05	0.000116	CcSEcCtD
Bexarotene—Skin disorder—Gabapentin—epilepsy syndrome	4.01e-05	0.000116	CcSEcCtD
Bexarotene—Somnolence—Pregabalin—epilepsy syndrome	4e-05	0.000116	CcSEcCtD
Bexarotene—RXRA—Metabolism—ADSL—epilepsy syndrome	4e-05	0.000463	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—H2AFX—epilepsy syndrome	3.99e-05	0.000462	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.99e-05	0.000116	CcSEcCtD
Bexarotene—Vomiting—Lamotrigine—epilepsy syndrome	3.98e-05	0.000115	CcSEcCtD
Bexarotene—RXRB—Gene Expression—VDR—epilepsy syndrome	3.96e-05	0.000459	CbGpPWpGaD
Bexarotene—Rash—Lamotrigine—epilepsy syndrome	3.95e-05	0.000114	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—HES1—epilepsy syndrome	3.95e-05	0.000457	CbGpPWpGaD
Bexarotene—Ill-defined disorder—Topiramate—epilepsy syndrome	3.95e-05	0.000114	CcSEcCtD
Bexarotene—Dermatitis—Lamotrigine—epilepsy syndrome	3.95e-05	0.000114	CcSEcCtD
Bexarotene—Abdominal pain—Valproic Acid—epilepsy syndrome	3.94e-05	0.000114	CcSEcCtD
Bexarotene—Body temperature increased—Valproic Acid—epilepsy syndrome	3.94e-05	0.000114	CcSEcCtD
Bexarotene—Anorexia—Gabapentin—epilepsy syndrome	3.93e-05	0.000114	CcSEcCtD
Bexarotene—Anaemia—Topiramate—epilepsy syndrome	3.93e-05	0.000114	CcSEcCtD
Bexarotene—Headache—Lamotrigine—epilepsy syndrome	3.92e-05	0.000114	CcSEcCtD
Bexarotene—RXRA—Metabolism—GLUL—epilepsy syndrome	3.92e-05	0.000454	CbGpPWpGaD
Bexarotene—Decreased appetite—Pregabalin—epilepsy syndrome	3.91e-05	0.000113	CcSEcCtD
Bexarotene—Agitation—Topiramate—epilepsy syndrome	3.91e-05	0.000113	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.89e-05	0.000113	CcSEcCtD
Bexarotene—Fatigue—Pregabalin—epilepsy syndrome	3.88e-05	0.000112	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.87e-05	0.000448	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR3C1—epilepsy syndrome	3.86e-05	0.000447	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—YWHAZ—epilepsy syndrome	3.85e-05	0.000446	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CACNA1D—epilepsy syndrome	3.85e-05	0.000446	CbGpPWpGaD
Bexarotene—Nausea—Carbamazepine—epilepsy syndrome	3.85e-05	0.000112	CcSEcCtD
Bexarotene—Constipation—Pregabalin—epilepsy syndrome	3.85e-05	0.000112	CcSEcCtD
Bexarotene—Pain—Pregabalin—epilepsy syndrome	3.85e-05	0.000112	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—FYN—epilepsy syndrome	3.84e-05	0.000445	CbGpPWpGaD
Bexarotene—Malaise—Topiramate—epilepsy syndrome	3.84e-05	0.000111	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.83e-05	0.000443	CbGpPWpGaD
Bexarotene—Vertigo—Topiramate—epilepsy syndrome	3.82e-05	0.000111	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—MEF2C—epilepsy syndrome	3.82e-05	0.000442	CbGpPWpGaD
Bexarotene—Syncope—Topiramate—epilepsy syndrome	3.81e-05	0.000111	CcSEcCtD
Bexarotene—Leukopenia—Topiramate—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Bexarotene—RXRG—Gene Expression—NR3C1—epilepsy syndrome	3.79e-05	0.000439	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.76e-05	0.000109	CcSEcCtD
Bexarotene—Palpitations—Topiramate—epilepsy syndrome	3.76e-05	0.000109	CcSEcCtD
Bexarotene—RXRB—Gene Expression—H2AFX—epilepsy syndrome	3.76e-05	0.000435	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA13—epilepsy syndrome	3.75e-05	0.000434	CbGpPWpGaD
Bexarotene—Loss of consciousness—Topiramate—epilepsy syndrome	3.74e-05	0.000108	CcSEcCtD
Bexarotene—Insomnia—Gabapentin—epilepsy syndrome	3.73e-05	0.000108	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.73e-05	0.000432	CbGpPWpGaD
Bexarotene—Nausea—Lamotrigine—epilepsy syndrome	3.72e-05	0.000108	CcSEcCtD
Bexarotene—Cough—Topiramate—epilepsy syndrome	3.71e-05	0.000108	CcSEcCtD
Bexarotene—Feeling abnormal—Pregabalin—epilepsy syndrome	3.71e-05	0.000107	CcSEcCtD
Bexarotene—Paraesthesia—Gabapentin—epilepsy syndrome	3.71e-05	0.000107	CcSEcCtD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.69e-05	0.000427	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.68e-05	0.000107	CcSEcCtD
Bexarotene—Dyspnoea—Gabapentin—epilepsy syndrome	3.68e-05	0.000107	CcSEcCtD
Bexarotene—Hypertension—Topiramate—epilepsy syndrome	3.67e-05	0.000106	CcSEcCtD
Bexarotene—Somnolence—Gabapentin—epilepsy syndrome	3.67e-05	0.000106	CcSEcCtD
Bexarotene—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.67e-05	0.000106	CcSEcCtD
Bexarotene—Dyspepsia—Gabapentin—epilepsy syndrome	3.63e-05	0.000105	CcSEcCtD
Bexarotene—RXRB—Gene Expression—YWHAZ—epilepsy syndrome	3.62e-05	0.000419	CbGpPWpGaD
Bexarotene—Arthralgia—Topiramate—epilepsy syndrome	3.62e-05	0.000105	CcSEcCtD
Bexarotene—Myalgia—Topiramate—epilepsy syndrome	3.62e-05	0.000105	CcSEcCtD
Bexarotene—Chest pain—Topiramate—epilepsy syndrome	3.62e-05	0.000105	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.62e-05	0.000419	CbGpPWpGaD
Bexarotene—Anxiety—Topiramate—epilepsy syndrome	3.61e-05	0.000105	CcSEcCtD
Bexarotene—RXRA—Metabolism—TXNRD1—epilepsy syndrome	3.6e-05	0.000417	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.6e-05	0.000104	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.59e-05	0.000416	CbGpPWpGaD
Bexarotene—Decreased appetite—Gabapentin—epilepsy syndrome	3.59e-05	0.000104	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.58e-05	0.000414	CbGpPWpGaD
Bexarotene—Discomfort—Topiramate—epilepsy syndrome	3.58e-05	0.000104	CcSEcCtD
Bexarotene—Asthenia—Valproic Acid—epilepsy syndrome	3.57e-05	0.000104	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.57e-05	0.000413	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR3C1—epilepsy syndrome	3.57e-05	0.000413	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.56e-05	0.000103	CcSEcCtD
Bexarotene—Fatigue—Gabapentin—epilepsy syndrome	3.56e-05	0.000103	CcSEcCtD
Bexarotene—Abdominal pain—Pregabalin—epilepsy syndrome	3.56e-05	0.000103	CcSEcCtD
Bexarotene—Body temperature increased—Pregabalin—epilepsy syndrome	3.56e-05	0.000103	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.55e-05	0.00041	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.54e-05	0.00041	CbGpPWpGaD
Bexarotene—Dry mouth—Topiramate—epilepsy syndrome	3.54e-05	0.000103	CcSEcCtD
Bexarotene—Pain—Gabapentin—epilepsy syndrome	3.53e-05	0.000102	CcSEcCtD
Bexarotene—Constipation—Gabapentin—epilepsy syndrome	3.53e-05	0.000102	CcSEcCtD
Bexarotene—Pruritus—Valproic Acid—epilepsy syndrome	3.52e-05	0.000102	CcSEcCtD
Bexarotene—Confusional state—Topiramate—epilepsy syndrome	3.5e-05	0.000101	CcSEcCtD
Bexarotene—RXRA—Metabolism—AQP1—epilepsy syndrome	3.5e-05	0.000405	CbGpPWpGaD
Bexarotene—Oedema—Topiramate—epilepsy syndrome	3.47e-05	0.000101	CcSEcCtD
Bexarotene—Infection—Topiramate—epilepsy syndrome	3.45e-05	0.0001	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.43e-05	0.000398	CbGpPWpGaD
Bexarotene—Shock—Topiramate—epilepsy syndrome	3.42e-05	9.9e-05	CcSEcCtD
Bexarotene—Diarrhoea—Valproic Acid—epilepsy syndrome	3.41e-05	9.87e-05	CcSEcCtD
Bexarotene—Nervous system disorder—Topiramate—epilepsy syndrome	3.4e-05	9.87e-05	CcSEcCtD
Bexarotene—Feeling abnormal—Gabapentin—epilepsy syndrome	3.4e-05	9.86e-05	CcSEcCtD
Bexarotene—Thrombocytopenia—Topiramate—epilepsy syndrome	3.4e-05	9.85e-05	CcSEcCtD
Bexarotene—Tachycardia—Topiramate—epilepsy syndrome	3.39e-05	9.82e-05	CcSEcCtD
Bexarotene—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.37e-05	9.78e-05	CcSEcCtD
Bexarotene—Skin disorder—Topiramate—epilepsy syndrome	3.37e-05	9.77e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.36e-05	0.000389	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Topiramate—epilepsy syndrome	3.36e-05	9.73e-05	CcSEcCtD
Bexarotene—Hypersensitivity—Pregabalin—epilepsy syndrome	3.32e-05	9.61e-05	CcSEcCtD
Bexarotene—Anorexia—Topiramate—epilepsy syndrome	3.31e-05	9.59e-05	CcSEcCtD
Bexarotene—Dizziness—Valproic Acid—epilepsy syndrome	3.29e-05	9.54e-05	CcSEcCtD
Bexarotene—Body temperature increased—Gabapentin—epilepsy syndrome	3.26e-05	9.46e-05	CcSEcCtD
Bexarotene—Abdominal pain—Gabapentin—epilepsy syndrome	3.26e-05	9.46e-05	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.24e-05	0.000375	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—EIF2S1—epilepsy syndrome	3.23e-05	0.000374	CbGpPWpGaD
Bexarotene—Asthenia—Pregabalin—epilepsy syndrome	3.23e-05	9.36e-05	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.2e-05	0.00037	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.2e-05	0.00037	CbGpPWpGaD
Bexarotene—Pruritus—Pregabalin—epilepsy syndrome	3.18e-05	9.23e-05	CcSEcCtD
Bexarotene—Vomiting—Valproic Acid—epilepsy syndrome	3.17e-05	9.17e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—KDR—epilepsy syndrome	3.16e-05	0.000366	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.16e-05	9.17e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—CHRM3—epilepsy syndrome	3.16e-05	0.000366	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—KCNJ11—epilepsy syndrome	3.16e-05	0.000366	CbGpPWpGaD
Bexarotene—Insomnia—Topiramate—epilepsy syndrome	3.14e-05	9.1e-05	CcSEcCtD
Bexarotene—Rash—Valproic Acid—epilepsy syndrome	3.14e-05	9.1e-05	CcSEcCtD
Bexarotene—Dermatitis—Valproic Acid—epilepsy syndrome	3.14e-05	9.09e-05	CcSEcCtD
Bexarotene—Headache—Valproic Acid—epilepsy syndrome	3.12e-05	9.04e-05	CcSEcCtD
Bexarotene—Paraesthesia—Topiramate—epilepsy syndrome	3.12e-05	9.04e-05	CcSEcCtD
Bexarotene—RXRA—Gene Expression—HSPB1—epilepsy syndrome	3.12e-05	0.000361	CbGpPWpGaD
Bexarotene—Dyspnoea—Topiramate—epilepsy syndrome	3.1e-05	8.97e-05	CcSEcCtD
Bexarotene—Somnolence—Topiramate—epilepsy syndrome	3.09e-05	8.95e-05	CcSEcCtD
Bexarotene—Diarrhoea—Pregabalin—epilepsy syndrome	3.08e-05	8.92e-05	CcSEcCtD
Bexarotene—Dyspepsia—Topiramate—epilepsy syndrome	3.06e-05	8.86e-05	CcSEcCtD
Bexarotene—Hypersensitivity—Gabapentin—epilepsy syndrome	3.04e-05	8.81e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—IL6ST—epilepsy syndrome	3.03e-05	0.000351	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.02e-05	0.000349	CbGpPWpGaD
Bexarotene—Decreased appetite—Topiramate—epilepsy syndrome	3.02e-05	8.75e-05	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3e-05	8.69e-05	CcSEcCtD
Bexarotene—Fatigue—Topiramate—epilepsy syndrome	2.99e-05	8.68e-05	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.99e-05	0.000346	CbGpPWpGaD
Bexarotene—Dizziness—Pregabalin—epilepsy syndrome	2.98e-05	8.63e-05	CcSEcCtD
Bexarotene—Pain—Topiramate—epilepsy syndrome	2.97e-05	8.61e-05	CcSEcCtD
Bexarotene—Constipation—Topiramate—epilepsy syndrome	2.97e-05	8.61e-05	CcSEcCtD
Bexarotene—Asthenia—Gabapentin—epilepsy syndrome	2.96e-05	8.58e-05	CcSEcCtD
Bexarotene—Nausea—Valproic Acid—epilepsy syndrome	2.96e-05	8.57e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.94e-05	0.000341	CbGpPWpGaD
Bexarotene—Pruritus—Gabapentin—epilepsy syndrome	2.92e-05	8.46e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.89e-05	0.000334	CbGpPWpGaD
Bexarotene—Vomiting—Pregabalin—epilepsy syndrome	2.86e-05	8.29e-05	CcSEcCtD
Bexarotene—Feeling abnormal—Topiramate—epilepsy syndrome	2.86e-05	8.29e-05	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—PDXK—epilepsy syndrome	2.84e-05	0.000329	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADK—epilepsy syndrome	2.84e-05	0.000329	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	2.84e-05	0.000329	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—FAR1—epilepsy syndrome	2.84e-05	0.000329	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	2.84e-05	0.000329	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CERS1—epilepsy syndrome	2.84e-05	0.000329	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.84e-05	8.23e-05	CcSEcCtD
Bexarotene—Rash—Pregabalin—epilepsy syndrome	2.84e-05	8.22e-05	CcSEcCtD
Bexarotene—Dermatitis—Pregabalin—epilepsy syndrome	2.83e-05	8.22e-05	CcSEcCtD
Bexarotene—Diarrhoea—Gabapentin—epilepsy syndrome	2.82e-05	8.18e-05	CcSEcCtD
Bexarotene—Headache—Pregabalin—epilepsy syndrome	2.82e-05	8.17e-05	CcSEcCtD
Bexarotene—Abdominal pain—Topiramate—epilepsy syndrome	2.74e-05	7.95e-05	CcSEcCtD
Bexarotene—Body temperature increased—Topiramate—epilepsy syndrome	2.74e-05	7.95e-05	CcSEcCtD
Bexarotene—Dizziness—Gabapentin—epilepsy syndrome	2.73e-05	7.91e-05	CcSEcCtD
Bexarotene—Nausea—Pregabalin—epilepsy syndrome	2.67e-05	7.75e-05	CcSEcCtD
Bexarotene—Vomiting—Gabapentin—epilepsy syndrome	2.62e-05	7.61e-05	CcSEcCtD
Bexarotene—Rash—Gabapentin—epilepsy syndrome	2.6e-05	7.54e-05	CcSEcCtD
Bexarotene—RXRA—Gene Expression—JUNB—epilepsy syndrome	2.6e-05	0.000301	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	2.6e-05	0.000301	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	2.6e-05	0.000301	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GAMT—epilepsy syndrome	2.6e-05	0.000301	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PNPO—epilepsy syndrome	2.6e-05	0.000301	CbGpPWpGaD
Bexarotene—Dermatitis—Gabapentin—epilepsy syndrome	2.6e-05	7.53e-05	CcSEcCtD
Bexarotene—Headache—Gabapentin—epilepsy syndrome	2.59e-05	7.49e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—ABCG2—epilepsy syndrome	2.58e-05	0.000298	CbGpPWpGaD
Bexarotene—Hypersensitivity—Topiramate—epilepsy syndrome	2.56e-05	7.41e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—CYP2C19—epilepsy syndrome	2.51e-05	0.000291	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP11A1—epilepsy syndrome	2.5e-05	0.000289	CbGpPWpGaD
Bexarotene—Asthenia—Topiramate—epilepsy syndrome	2.49e-05	7.22e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.48e-05	0.000287	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.47e-05	0.000286	CbGpPWpGaD
Bexarotene—Pruritus—Topiramate—epilepsy syndrome	2.46e-05	7.12e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—FGF2—epilepsy syndrome	2.45e-05	0.000284	CbGpPWpGaD
Bexarotene—Nausea—Gabapentin—epilepsy syndrome	2.45e-05	7.1e-05	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—QDPR—epilepsy syndrome	2.42e-05	0.00028	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA4—epilepsy syndrome	2.42e-05	0.00028	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	2.41e-05	0.000279	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.38e-05	0.000275	CbGpPWpGaD
Bexarotene—Diarrhoea—Topiramate—epilepsy syndrome	2.38e-05	6.89e-05	CcSEcCtD
Bexarotene—Dizziness—Topiramate—epilepsy syndrome	2.3e-05	6.65e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—RELA—epilepsy syndrome	2.28e-05	0.000264	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—COX3—epilepsy syndrome	2.27e-05	0.000263	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.26e-05	0.000262	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2D6—epilepsy syndrome	2.25e-05	0.000261	CbGpPWpGaD
Bexarotene—Vomiting—Topiramate—epilepsy syndrome	2.21e-05	6.4e-05	CcSEcCtD
Bexarotene—Rash—Topiramate—epilepsy syndrome	2.19e-05	6.34e-05	CcSEcCtD
Bexarotene—Dermatitis—Topiramate—epilepsy syndrome	2.19e-05	6.34e-05	CcSEcCtD
Bexarotene—Headache—Topiramate—epilepsy syndrome	2.17e-05	6.3e-05	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	2.15e-05	0.000249	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PFKL—epilepsy syndrome	2.15e-05	0.000249	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	2.15e-05	0.000249	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	2.15e-05	0.000249	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	2.15e-05	0.000249	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.15e-05	0.000249	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADRA2A—epilepsy syndrome	2.14e-05	0.000248	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—BCHE—epilepsy syndrome	2.14e-05	0.000247	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.11e-05	0.000244	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SIRT1—epilepsy syndrome	2.09e-05	0.000242	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.09e-05	0.000242	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—VDR—epilepsy syndrome	2.06e-05	0.000239	CbGpPWpGaD
Bexarotene—Nausea—Topiramate—epilepsy syndrome	2.06e-05	5.98e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—SLC2A1—epilepsy syndrome	2.04e-05	0.000236	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLCB1—epilepsy syndrome	2.02e-05	0.000233	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TH—epilepsy syndrome	2.01e-05	0.000232	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.98e-05	0.000229	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.97e-05	0.000228	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.97e-05	0.000228	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.97e-05	0.000228	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—H2AFX—epilepsy syndrome	1.96e-05	0.000227	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—epilepsy syndrome	1.94e-05	0.000225	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.9e-05	0.00022	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—YWHAZ—epilepsy syndrome	1.89e-05	0.000219	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.87e-05	0.000217	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.87e-05	0.000217	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.87e-05	0.000217	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.87e-05	0.000217	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.87e-05	0.000217	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.87e-05	0.000217	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR3C1—epilepsy syndrome	1.86e-05	0.000215	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.83e-05	0.000212	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.83e-05	0.000212	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.79e-05	0.000207	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SRC—epilepsy syndrome	1.79e-05	0.000207	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—epilepsy syndrome	1.74e-05	0.000202	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.72e-05	0.000199	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.71e-05	0.000198	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.71e-05	0.000198	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.71e-05	0.000198	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.71e-05	0.000198	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—epilepsy syndrome	1.68e-05	0.000194	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.68e-05	0.000194	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAT—epilepsy syndrome	1.65e-05	0.000191	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.63e-05	0.000189	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.63e-05	0.000189	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCB1—epilepsy syndrome	1.61e-05	0.000186	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.59e-05	0.000185	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.59e-05	0.000185	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.59e-05	0.000184	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.56e-05	0.00018	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.56e-05	0.00018	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.52e-05	0.000176	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.5e-05	0.000173	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GPX1—epilepsy syndrome	1.5e-05	0.000173	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—epilepsy syndrome	1.49e-05	0.000173	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.49e-05	0.000173	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.46e-05	0.00017	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.44e-05	0.000166	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.42e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.42e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.42e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.42e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.42e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.34e-05	0.000156	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AGT—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.31e-05	0.000151	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.3e-05	0.00015	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.3e-05	0.00015	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.3e-05	0.00015	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—epilepsy syndrome	1.28e-05	0.000149	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.25e-05	0.000145	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.25e-05	0.000145	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.21e-05	0.00014	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.21e-05	0.00014	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—epilepsy syndrome	1.16e-05	0.000134	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.14e-05	0.000131	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.1e-05	0.000127	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—epilepsy syndrome	1.09e-05	0.000126	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.03e-05	0.000119	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.03e-05	0.000119	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—epilepsy syndrome	1.01e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.01e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADSL—epilepsy syndrome	9.85e-06	0.000114	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLUL—epilepsy syndrome	9.66e-06	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	9.62e-06	0.000111	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.48e-06	0.00011	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	9.38e-06	0.000109	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	9.32e-06	0.000108	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.25e-06	0.000107	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	8.87e-06	0.000103	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—epilepsy syndrome	8.8e-06	0.000102	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.61e-06	9.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.44e-06	9.76e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	8.41e-06	9.74e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	8.01e-06	9.27e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BCHE—epilepsy syndrome	7.97e-06	9.23e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	7.79e-06	9.01e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	7.79e-06	9.01e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	7.61e-06	8.81e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	7.52e-06	8.71e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TH—epilepsy syndrome	7.5e-06	8.68e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.38e-06	8.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.35e-06	7.35e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	6.26e-06	7.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.18e-06	7.16e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.17e-06	7.15e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.15e-06	7.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.01e-06	6.95e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—epilepsy syndrome	5.69e-06	6.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPX1—epilepsy syndrome	5.58e-06	6.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.55e-06	6.42e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.28e-06	6.11e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.26e-06	6.09e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.02e-06	5.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.96e-06	5.74e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TH—epilepsy syndrome	4.94e-06	5.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AGT—epilepsy syndrome	4.9e-06	5.67e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—epilepsy syndrome	4.8e-06	5.55e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—epilepsy syndrome	4.42e-06	5.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.13e-06	4.78e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.12e-06	4.77e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.07e-06	4.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.96e-06	4.58e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.76e-06	4.35e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.68e-06	4.26e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.29e-06	3.8e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.23e-06	3.74e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.16e-06	3.66e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.72e-06	3.15e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.48e-06	2.87e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.17e-06	2.51e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.65e-06	1.91e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.09e-06	1.26e-05	CbGpPWpGaD
